Information Provided By: 
Fly News Breaks for May 20, 2019
NDRA
May 20, 2019 | 09:05 EDT
Lake Street analyst Brooks O'Neil started Endra Life Sciences with a Buy rating and $7 price target. The company's next generation platform, Thermo Acoustic Enhanced Ultrasound, improves the common ultrasound with a radio frequency-based overlay to diagnose non- alcoholic fatty liver disease, O'Neil tells investors in a research note. He points out that NAFLD affects more than 1.4B people around the world. Further, he believes Endra's relationship with "ultrasound leader" GE Healthcare should speed up the company's commercialization.
News For NDRA From the Last 2 Days
There are no results for your query NDRA
